ICARES Medicus, Inc. Share Price

Equities

6612

TW0006612005

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
133 TWD -2.92% Intraday chart for ICARES Medicus, Inc. -3.27% +5.56%

Financials

Sales 2022 512M 15.71M 1.26B Sales 2023 605M 18.58M 1.49B Capitalization 4.93B 151M 12.11B
Net income 2022 129M 3.96M 317M Net income 2023 97M 2.98M 238M EV / Sales 2022 4.6 x
Net cash position 2022 421M 12.91M 1.03B Net cash position 2023 825M 25.33M 2.03B EV / Sales 2023 6.79 x
P/E ratio 2022
21.4 x
P/E ratio 2023
45.2 x
Employees -
Yield 2022
1.23%
Yield 2023
0.16%
Free-Float 48.97%
More Fundamentals * Assessed data
Dynamic Chart
ICARES Medicus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
ICARES Medicus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
ICARES Medicus, Inc.(TPEX:6612) added to S&P Global BMI Index CI
ICARES Medicus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
ICARES Medicus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
ICARES Medicus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
ICARES Medicus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
ICARES Medicus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
ICARES Medicus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
ICARES Medicus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
ICARES Medicus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Icares Medicus, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Icares Medicus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Icares Medicus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Icares Medicus, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
More news
1 day-2.92%
1 week-3.27%
Current month+19.82%
1 month+25.47%
3 months+11.76%
6 months+3.10%
Current year+5.56%
More quotes
1 week
133.00
Extreme 133
154.00
1 month
109.00
Extreme 109
154.00
Current year
106.00
Extreme 106
154.00
1 year
106.00
Extreme 106
198.50
3 years
59.00
Extreme 59
198.50
5 years
47.00
Extreme 47
198.50
10 years
38.95
Extreme 38.95
198.50
More quotes
Managers TitleAgeSince
Chief Executive Officer - 13/07/11
President - 13/07/11
Director of Finance/CFO - 14/06/16
Members of the board TitleAgeSince
Director/Board Member - 20/04/14
Chief Executive Officer - 13/07/11
Chief Tech/Sci/R&D Officer - 12/02/15
More insiders
Date Price Change Volume
26/04/24 133 -2.92% 220,511
25/04/24 137 -2.49% 274,206
24/04/24 140.5 -2.43% 306,342
23/04/24 144 -4.00% 788,589
22/04/24 150 +9.09% 1,262,513

End-of-day quote Taipei Exchange, April 25, 2024

More quotes
Icares Medicus Inc is a Taiwan-based company mainly engaged in the authorization of high-end medical material surface treatment technology. The Company is also involved in the sale of surface treatment formulations and provision of customer surface treatment processing services, as well as the research and development, manufacture and sale of artificial lens and its implantation system. The Company's product revenue is mainly divided into three categories. The royalty income comes from the authorization of implantation/invasive high-end medical material surface treatment technology. The technical service income mainly includes implantation/invasive high-end medical surface treatment services, provision of medical coatings and foundry of artificial lens implantation systems. The sales of medical materials mainly include the sales of medical materials surface inspection equipment and other products. The Company distributes its products in domestic and overseas markets.
More about the company